Quality of life among cancer patients

Nayak, Malathi G; George, Anice; Vidyasagar, M S; Mathew, Stanley; Nayak, Sudhakar; Nayak, Baby S; Shashidhara, YN; Kamath, Asha

doi:10.4103/ijpc.ijpc_82_17

Cited by 260 publications

(185 citation statements)

References 21 publications

Supporting

Mentioning

155

Contrasting

Unclassified

Order By: Relevance

“…A study by Nayak MG et al, including a number of participants very similar to the number of subjects in our own research, showed that the mental well-being of the respondents influenced feelings of significant depression among 54.4% of participants and that the majority (98.3%) did not feel comfortable taking part in social life. Most of the patients feared disease recurrence (76.2%) and disability (62.1%) [ 26 ]. A comprehensive study of a US oncology centre involving nearly 4500 patients aged 19 years and older showed high rates of psychological symptoms that met the criteria for clinical diagnoses such as depression, adaptive disorders and anxiety, which was confirmed by subsequent studies by other scientists [ 27 , 28 , 29 ].…”

Section: Discussionmentioning

confidence: 99%

Quality of Life of Cancer Patients Treated with Chemotherapy

Lewandowska

Rudzki

Lewandowski

et al. 2020

IJERPH

124

View full text Add to dashboard Cite

Background: Life-quality tests are the basis for assessing the condition of oncological patients. They allow for obtaining valuable information from the patients regarding not only the symptoms of disease and adverse effects of the treatment but also assessment of the psychological, social and spiritual aspects. Taking into account assessment of the quality of life made by the patient in the course of disease has a positive effect on the well-being of patients, their families and their caregivers as well as on satisfaction with the interdisciplinary and holistic oncological care. Methods: A population-based, multi-area cross-sectional study was conducted among patients with cancer in the study in order to assess their life quality. The method used in the study was a clinical interview. Quality of life was measured using the EQ-5D-5L Quality of Life Questionnaire, the Karnofsky Performance Status, our own symptom checklist, Edmonton Symptom Assessment and Visual Analogue Scale. Results: In the subjective assessment of fitness, after using the Karnofsky fitness index, it was shown that 28% (95% CI (confidence interval): 27–30) of patients declared the ability to perform normal physical activity. In the assessment the profile, quality of life and psychometric properties of EQ-5D-5L, it was shown that patients had the most severe problems in terms of self-care (81%, 95% CI: 76–89) and feeling anxious and depressed (63%, 95% CI: 60–68). Conclusions: Cancer undoubtedly has a negative impact on the quality of life of patients, which is related to the disease process itself, the treatment used and the duration of the disease.

show abstract

Section: Discussionmentioning

confidence: 99%

Quality of Life of Cancer Patients Treated with Chemotherapy

Lewandowska

Rudzki

Lewandowski

et al. 2020

IJERPH

124

View full text Add to dashboard Cite

show abstract

“…Several studies have shown that quality of life in cancer patients was low. (Nayak et al, 2017;Driessen et al, 2012). Low quality of life will be displayed by a decrease in physical conditions, poor social/family relationships, unstable mood conditions, and functional conditions in living everyday life and at work becomes low.…”

Section: Discussionmentioning

confidence: 99%

Self-Efficacy Training Improved The Quality of Life for Cancer Patients Undergoing Chemotherapy

Gultom¹,

Indrawati²

2020

GJHS

View full text Add to dashboard Cite

The survival of cancer patients is often short despite receiving therapy, but it really depends on various things including those that play an important role is the ability of patients to improve their life status in dealing with illnesses and therapy through increased self-efficacy because self-efficacy of cancer patients often experience reduction due to cancer and the therapy it undergoes. The pre–test and  the first post -test and also  the second post-test research design in the form of self-efficacy training of cancer patients undergoing chemotherapy used  a quasi-experimental design without a control group. Data analysis used dependent t test and repeat ANOVA test. There were significant effects and differences in self-efficacy training on the quality of life of cancer patients undergoing chemotherapy with the  p value dependent test was 0,000 and the repeat ANOVA test was p value 0,000. The uses of structured self-efficacy training be one of the considerations of nursing interventions to improve the quality of life of cancer patients undergoing chemotherapy.

show abstract

“…17 However, during chemotherapy treatment, patients often develop disease-related and chemotherapy-related symptoms, such as pain, nausea, depression, and gastrointestinal complications, among others, which affect overall well-being and quality of life. 18 Many of these treatment-related symptoms are managed with medications commonly referred to as "supportive care medications, " such as clopidogrel, omeprazole, ondansetron, voriconazole, warfarin, and others. Most supportive care regimens for patients undergoing chemotherapy include multiple drugs with well-characterized drug-gene prescribing guidance.…”

Section: Rationale For Preemptive Panel-based Testingmentioning

confidence: 99%

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A Tutorial

Marrero

Cicali

Arwood

et al. 2020

Clin Pharma and Therapeutics

View full text Add to dashboard Cite

There have been significant advancements in precision medicine and approaches to medication selection based on pharmacogenetic results. With the availability of direct‐to‐consumer genetic testing and growing awareness of genetic interindividual variability, patient demand for more precise, individually tailored drug regimens is increasing. The University of Florida (UF) Health Precision Medicine Program (PMP) was established in 2011 to improve integration of genomic data into clinical practice. In the ensuing years, the UF Health PMP has successfully implemented several single‐gene tests to optimize the precision of medication prescribing across a variety of clinical settings. Most recently, the UF Health PMP launched a custom‐designed pharmacogenetic panel, including pharmacogenes relevant to supportive care medications commonly prescribed to patients undergoing chemotherapy treatment, referred to as “GatorPGx.” This tutorial provides guidance and information to institutions on how to transition from the implementation of single‐gene pharmacogenetic testing to a preemptive panel‐based testing approach. Here, we demonstrate application of the preemptive panel in the setting of an adult solid tumor oncology clinic. Importantly, the information included herein can be applied to other clinical practice settings.

show abstract

Quality of life among cancer patients

Cited by 260 publications

References 21 publications

Quality of Life of Cancer Patients Treated with Chemotherapy

Quality of Life of Cancer Patients Treated with Chemotherapy

Self-Efficacy Training Improved The Quality of Life for Cancer Patients Undergoing Chemotherapy

How to Transition from Single‐Gene Pharmacogenetic Testing to Preemptive Panel‐Based Testing: A Tutorial

Contact Info

Product

Resources

About